Evidence map›Paper›PMID 41067861›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Claus Madsen, Helle D Zacho, Dan Fuglø, Kayalvily Nielsen, Per Kongsted, Rasmus Bisbjerg, Maria Pedersen, Rikke Broholm, Christian Haarmark, Peter B Østergren

Abstract readComparative Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Risk of bone metastases on [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Claus MadsenDepartment of Nuclear Medicine, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark; claus.madsen@regionh.dk.
Helle D ZachoDepartment of Nuclear Medicine and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.
Dan FugløDepartment of Nuclear Medicine, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Kayalvily NielsenDepartment of Radiology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Per KongstedDepartment of Oncology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark; and.
Rasmus BisbjergDepartment of Urology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Maria PedersenDepartment of Nuclear Medicine, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Rikke BroholmDepartment of Nuclear Medicine, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Christian HaarmarkDepartment of Nuclear Medicine, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Peter B ØstergrenDepartment of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiolabeled prostate-specific membrane antigen (PSMA) PET/CT has demonstrated superior diagnostic accuracy for staging prostate cancer (PC) compared with conventional imaging modalities. However, the clinical impact of replacing

Indexed as

Fluorine RadioisotopesOligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsSodium FluorideAgedAged, 80 and overAntigens, SurfaceHumansMaleMiddle AgedNeoplasm StagingNiacinamideProspective StudiesAntigens, SurfaceFluorine-18Fluorine RadioisotopesNiacinamideOligopeptidesPSMA-1007Sodium Fluoride18F-NaF PET/CT18F-PSMA PET/CTclinical impactprostate cancerstagingtreatment

Identifiers

PMID41067861
PMCPMC12676649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.